Limited incremental value and cross-cohort transferability of CT radiomics for survival prediction after TACE in hepatocellular carcinoma
Abdominal Radiology · 13.10.2026
DOI: 10.1007/s00261-026-05830-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 13.10.2026. Verfasst von Krzysztof Bartnik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Radiology, Medical University of Warsaw, Warsaw, Poland. krzysztof.bartnik@wum.edu.pl. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate whether pretreatment CT radiomics adds information for overall survival (OS) prediction among patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE), and assess frozen imaging-model performance in an independent cohort.
Methods
This retrospective study included 221 WAW-TACE and 98 HCC-TACE-SEG patients with pretreatment arterial and portal venous CT. Incremental value of a tumor-radiomics Random Survival Forest score (R1) beyond cohort-specific clinical Cox models (C0) was evaluated within each cohort using 5-fold cross-validation repeated 10 times. External validation was restricted to frozen WAW-trained R1 models (Top-K = 5, 10, 15) applied to HCC-TACE-SEG without refitting; the combined C0 + R1 model was not externally validated.
Results
WAW-TACE included 162 deaths and HCC-TACE-SEG 86 deaths. In WAW-TACE, C0, R1 Top-K = 15, and C0 + R1 achieved C-indices of 0.646 ± 0.043, 0.593 ± 0.049, and 0.639 ± 0.045, respectively. Corresponding HCC-TACE-SEG estimates were 0.496 ± 0.087, 0.530 ± 0.072, and 0.495 ± 0.094. Thus, R1 did not consistently improve cohort-specific clinical reference models. In frozen external application, Top-K = 5, 10, and 15 achieved C-indices of 0.463 (95% CI 0.397–0.532), 0.535 (0.468–0.608), and 0.528 (0.460–0.598), respectively.
Conclusion
The evaluated models showed no consistent incremental value for OS prediction within these TACE cohorts and limited frozen-model discrimination in the clinically distinct HCC-TACE-SEG cohort. These findings do not support clinical use of these models or establish a general limitation of CT radiomics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Radiology, Medical University of Warsaw, Warsaw, Poland. krzysztof.bartnik@wum.edu.pl.
- Centre for Credible Artificial Intelligence, Warsaw University of Technology, Warsaw, Poland. krzysztof.bartnik@wum.edu.pl.
- Second Department of Radiology, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Belgutei Tsevegmed
Zitieren
APA
Bartnik, K., & Tsevegmed, B. (2026). Limited incremental value and cross-cohort transferability of CT radiomics for survival prediction after TACE in hepatocellular carcinoma. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05830-5
Vancouver
Bartnik K, Tsevegmed B. Limited incremental value and cross-cohort transferability of CT radiomics for survival prediction after TACE in hepatocellular carcinoma. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05830-5
BibTeX
@article{Bartnik2026,
author = {Bartnik, Krzysztof and Tsevegmed, Belgutei},
title = {Limited incremental value and cross-cohort transferability of CT radiomics for survival prediction after TACE in hepatocellular carcinoma},
journal = {Abdominal Radiology},
year = {2026},
doi = {10.1007/s00261-026-05830-5}
}
EUVIMED